WITNESSETHDistribution and Development Agreement • November 19th, 2004 • Stentor Inc • California
DISTRIBUTION AND DEVELOPMENT AGREEMENTDistribution and Development Agreement • March 13th, 2020 • Ritter Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Distribution and Development Agreement (this “Agreement”) is made and entered into as of May 1, 2016 by and between Sekisui Diagnostics, LLC and its Affiliates, a Delaware limited liability company with principal offices at 4 Hartwell Place, Lexington, Massachusetts 02421 (“Sekisui”), and Qualigen, Inc. and its Affiliates, a Delaware corporation with principal offices at 2042 Corte Del Nogal, Carlsbad, California 92011 (“Qualigen” and together with Sekisui, each a “Party” and together the “Parties”).
EXHIBIT 10.1 MARKETING, DISTRIBUTION AND DEVELOPMENT AGREEMENTDistribution and Development Agreement • May 15th, 2001 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations • New York
Amendment to Distribution and Development AgreementDistribution and Development Agreement • August 13th, 2021 • Qualigen Therapeutics, Inc. • Pharmaceutical preparations
This Amendment to Distribution and Development Agreement (this “Amendment”) is entered into by and between Sekisui Diagnostics, LLC, a Delaware limited liability company (“Sekisui”), and Qualigen, Inc., a Delaware corporation (“Qualigen”), as of July 1, 2021. This Amendment amends that certain Distribution and Development Agreement dated May 1, 2016 between Sekisui and Qualigen (as amended to the date hereof, the “Distribution and Development Agreement”).
Amendment to Distribution and Development AgreementDistribution and Development Agreement • March 13th, 2020 • Ritter Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment to Distribution and Development Agreement (this “Amendment”) is entered into by and between Sekisui Diagnostics, LLC, a Delaware limited liability company (“Sekisui”), and Qualigen, Inc., a Delaware corporation (“Qualigen”), and shall be effective as of April 2, 2018. This Amendment amends that certain Distribution and Development Agreement dated May 1, 2016 between Sekisui and Qualigen, as amended to the date hereof (collectively, the “Distribution and Development Agreement”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. SECOND AMENDMENT TO DISTRIBUTION AND DEVELOPMENT AGREEMENTDistribution and Development Agreement • November 18th, 2004 • Idx Systems Corp • Services-computer integrated systems design
This Second Amendment (the “Second Amendment”) of the Distribution and Development Agreement (the “Original Agreement”) between STENTOR, INC., a Delaware corporation (“Stentor”) and IDX SYSTEMS CORPORATION, a Vermont corporation (“IDX”) is made effective as of November 16, 2004 (the “Second Amendment Effective Date”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. AMENDMENT TO DISTRIBUTION AND DEVELOPMENT AGREEMENTDistribution and Development Agreement • March 15th, 2004 • Idx Systems Corp • Services-computer integrated systems design
This Amendment (“Amendment”) is made effective as of January 1, 2004 (the “Amendment Effective Date”) by and between, STENTOR, INC., a Delaware corporation (“Stentor”), and IDX SYSTEMS CORPORATION, a Vermont corporation (“IDX”).
